CRISPR

Natural killer cells can sometimes attack beneficial CAR T cell immunotherapies. Now, researchers have discovered why and a potential way to stop them.

A new method called “REVeRT” expands the capabilities of gene delivery platforms by transporting larger genes than previously possible.  

CRISPR-edited immune cells may help patients with T-cell leukemia, albeit with immunotherapy-related risks.

Negative childhood experiences can leave epigenetic scars that haunt organisms for life.

For decades, treatment options for sickle cell disease have been extremely limited. Soon, gene therapies and a host of pharmaceuticals could alleviate the immense burden of this disease.

Mireille Kamariza develops new chemistry-driven diagnostics for tuberculosis that can reduce the time to treatment from weeks to minutes.

Currently, the only cure for alpha thalassemia is a bone marrow transplant, but the success of gene therapies for related conditions points to a potential new cure.

Genome-wide CRISPR screens in living organisms reveal mechanisms that cell culture studies overlook.

George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.

Researchers correcting the genetic causes of disease at the DNA or RNA level make their cases.